GIST patient registry study
Part of Cancer, Digestive system clinical trials.
This study is creating a registry to track people with GIST over time. Participating helps researchers learn more about the disease and improve future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with GIST (gastrointestinal stromal tumor).
- You are willing to sign a consent form to join the registry.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is building a large database of information about people with GIST (gastrointestinal stromal tumors). By joining, you help doctors learn more about the disease and improve care for everyone with GIST.
This study looks at how surgery for gastrointestinal stromal tumors (GIST) works, and collects tumor samples to study them under the microscope and by DNA testing. Your results may help researchers better predict tumor behavior and guide future treatment.
This trial studies advanced GIST cancers that have stopped responding to all four standard treatments. It uses PET-CT scans and genetic testing of tumor tissue to understand resistance, helping to find the best next treatment.
This trial tests a new drug called NB003 for people with advanced GIST (a type of stomach or intestinal tumor) that has stopped responding to or could not be tolerated after standard treatments like imatinib or sunitinib. The goal is to see if NB003 can help shrink or control the tumor.
This trial tests a new targeted therapy drug, DCC-3009, for people with advanced GIST that has a specific gene mutation (KIT or PDGFRA). It's for those who have already tried other targeted treatments and need a new option.
This study looks at stomach (gastric) and esophagus cancer, using clinical information and tissue samples. It may help researchers better understand these cancers and improve future care.
Hear when a new GIST trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.